Alkeon Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Hold |
4,698,100
| – | – | 0.02% | 71 |
|
|
2025
Q1 | $10.6M | Hold |
4,698,100
| – | – | 0.02% | 72 |
|
|
2024
Q4 | $16.4M | Hold |
4,698,100
| – | – | 0.03% | 64 |
|
|
2024
Q3 | $19.3M | Hold |
4,698,100
| – | – | 0.03% | 64 |
|
|
2024
Q2 | $16.9M | Buy |
4,698,100
+460,000
| +11% | +$1.66M | 0.03% | 71 |
|
|
2024
Q1 | $14M | Hold |
4,238,100
| – | – | 0.02% | 66 |
|
|
2023
Q4 | $9.79M | Buy |
4,238,100
+500,000
| +13% | +$1.16M | 0.02% | 69 |
|
|
2023
Q3 | $4.82M | Hold |
3,738,100
| – | – | 0.01% | 79 |
|
|
2023
Q2 | $4.93M | Buy |
3,738,100
+1,352,500
| +57% | +$1.79M | 0.01% | 89 |
|
|
2023
Q1 | $1.69M | Buy |
2,385,600
+250,000
| +12% | +$177K | ﹤0.01% | 99 |
|
|
2022
Q4 | $1.6M | Hold |
2,135,600
| – | – | 0.01% | 101 |
|
|
2022
Q3 | $1.84M | Buy |
2,135,600
+400,000
| +23% | +$344K | 0.01% | 106 |
|
|
2022
Q2 | $1.94M | Sell |
1,735,600
-200,000
| -10% | -$224K | 0.01% | 112 |
|
|
2022
Q1 | $2.17M | Hold |
1,935,600
| – | – | ﹤0.01% | 113 |
|
|
2021
Q4 | $3.1M | Hold |
1,935,600
| – | – | 0.01% | 130 |
|
|
2021
Q3 | $4.68M | Hold |
1,935,600
| – | – | 0.01% | 147 |
|
|
2021
Q2 | $6.14M | Hold |
1,935,600
| – | – | 0.01% | 135 |
|
|
2021
Q1 | $6.52M | Hold |
1,935,600
| – | – | 0.01% | 127 |
|
|
2020
Q4 | $6.93M | Buy |
+1,935,600
| New | +$6.93M | 0.01% | 123 |
|